Autolus Therapeutics Operating Expenses Growth & History (AUTL)

Autolus Therapeutics's operating expenses was $249.6M for fiscal 2025.

View full Autolus Therapeutics company overview

Autolus Therapeutics annual operating expenses history

Autolus Therapeutics annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31$249.6M$9.4M+3.92%
20242024-12-31$240.2M$58.8M+32.39%
20232023-12-31$181.4M$32.3M+21.67%
20222022-12-31$149.1M
20182018-09-30$57.5M$34.1M+145.68%
2017 · Sep 302017-09-30$23.4M$9.0M+62.90%
20162016-09-30$14.4M

Autolus Therapeutics operating expenses trends

Between the periods ended 2016-09-30 and 2025-12-31, Autolus Therapeutics's operating expenses increased from $14.4M to $249.6M, a change of $235.2M. The latest reported quarter, Q2 2026, shows $69.1M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Autolus Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about AUTL yet. Start the conversation.

Write the first post